Money Matters - Simplified

walking deformities

Ampyra, Acorda’s drug for multiple sclerosis, gets FDA nod

Rochester, NY, January 23 -- The Food and Drug Administration (FDA) gave its nod to a drug meant for patients suffering from multiple sclerosis (MS) and those who experience difficulties in walking.